# FDA 483 - Lawrence M. Lehrner MD - October 14, 2020

Source: https://www.keypedia.com/records/483/lawrence-m-lehrner-md/c1f9276d-befd-4904-b6ff-2f002e4af6ad

> FDA 483 for Lawrence M. Lehrner MD on October 14, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lawrence M. Lehrner MD
- Inspection Date: 2020-10-14
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: Lawrence M. Lehner MD, a clinical investigator in Las Vegas, NV, was cited for significant deviations from a study protocol during an FDA inspection. The firm failed to timely report serious adverse events for multiple subjects and administered incorrect doses of randomized treatment. These issues indicate a serious lack of adherence to clinical trial regulations and investigator responsibilities.

## Related Officers

- [investigator](https://www.keypedia.com/people/rebecca-t-davis/a821f7ef-0c73-4be1-9a9b-3fc2c07f88c1)

Company: https://www.keypedia.com/companies/lawrence-m-lehrner-md/28186470-e7c1-48a7-b4ee-f7d0004945a2

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b